6.01
price down icon3.69%   -0.23
after-market Handel nachbörslich: 6.01
loading
Schlusskurs vom Vortag:
$6.24
Offen:
$6.2
24-Stunden-Volumen:
1.27M
Relative Volume:
0.88
Marktkapitalisierung:
$926.32M
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-5.4144
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+1.01%
1M Leistung:
-18.12%
6M Leistung:
-60.20%
1J Leistung:
-2.59%
1-Tages-Spanne:
Value
$5.98
$6.245
1-Wochen-Bereich:
Value
$5.92
$6.30
52-Wochen-Spanne:
Value
$4.25
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Firmenname
Wave Life Sciences Ltd
Name
Telefon
617-949-2900
Name
Adresse
7 STRAITS VIEW, SINGAPORE
Name
Mitarbeiter
288
Name
Twitter
@WAVELifeSci
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
WVE's Discussions on Twitter

Vergleichen Sie WVE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
WVE
Wave Life Sciences Ltd
6.01 917.10M 53.61M -142.52M -141.83M -1.11
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-29 Eingeleitet Cantor Fitzgerald Overweight
2025-04-08 Eingeleitet Wedbush Outperform
2025-02-25 Eingeleitet Jefferies Buy
2024-10-16 Hochstufung Raymond James Outperform → Strong Buy
2024-09-27 Fortgesetzt JP Morgan Overweight
2024-09-19 Eingeleitet B. Riley Securities Buy
2024-09-09 Eingeleitet JP Morgan Overweight
2024-05-15 Eingeleitet Wells Fargo Overweight
2023-12-19 Hochstufung Leerink Partners Market Perform → Outperform
2023-07-05 Eingeleitet Raymond James Outperform
2023-05-24 Herabstufung Jefferies Buy → Hold
2020-12-15 Fortgesetzt H.C. Wainwright Buy
2020-10-23 Eingeleitet RBC Capital Mkts Sector Perform
2019-12-31 Herabstufung SVB Leerink Outperform → Mkt Perform
2019-11-01 Eingeleitet Guggenheim Buy
2019-07-15 Eingeleitet Cowen Market Perform
2019-04-17 Bestätigt H.C. Wainwright Buy
2018-08-07 Eingeleitet Stifel Buy
2018-07-23 Eingeleitet H.C. Wainwright Buy
2018-03-19 Bestätigt Mizuho Buy
2017-02-15 Eingeleitet H.C. Wainwright Buy
2016-11-10 Fortgesetzt Leerink Partners Outperform
2015-12-07 Eingeleitet JMP Securities Mkt Outperform
2015-12-07 Eingeleitet Jefferies Buy
2015-12-07 Eingeleitet Leerink Partners Outperform
2015-12-07 Eingeleitet Sun Trust Rbsn Humphrey Buy
Alle ansehen

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

pulisher
May 30, 2025

Nuveen Asset Management LLC Has $6.85 Million Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 30, 2025
pulisher
May 29, 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference | WVE Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Wave Life Sciences to Present at 2025 Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Wave Life Sciences CEO Reveals Next-Gen RNA Medicine Plans at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment Of Dr. Christopher Wright As Chief Medical Officer - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WV - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Wave Life Sciences (WVE) Appoints New Chief Medical Officer | WVE Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Harvard Professor to Chief Medical Officer: Wave Life Sciences Taps RNA Expert Behind Breakthrough FDA Approvals - Stock Titan

May 28, 2025
pulisher
May 28, 2025

WaVe Life Sciences’ SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $648,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 28, 2025
pulisher
May 28, 2025

Bank of America Corp DE Acquires 160,820 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 28, 2025
pulisher
May 27, 2025

Deutsche Bank AG Purchases 25,756 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 27, 2025
pulisher
May 23, 2025

Is Wave Life Sciences (WVE) the Best Low Priced Biotech Stock to Buy Now? - MSN

May 23, 2025
pulisher
May 18, 2025

BNP Paribas Financial Markets Increases Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 18, 2025
pulisher
May 17, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Rating of “Buy” by Analysts - Defense World

May 17, 2025
pulisher
May 17, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Holdings Increased by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

(WVE) On The My Stocks Page - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

FY2025 Earnings Estimate for WVE Issued By Cantor Fitzgerald - Defense World

May 15, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes $157,000 Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

May 14, 2025
pulisher
May 12, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

H.C. Wainwright maintains $22 target on WAVE Life Sciences stock By Investing.com - Investing.com India

May 12, 2025
pulisher
May 11, 2025

Wave Life Sciences (NASDAQ:WVE) Stock Rating Lowered by StockNews.com - Defense World

May 11, 2025
pulisher
May 10, 2025

Wave Life Sciences First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st

May 09, 2025
pulisher
May 09, 2025

RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | WVE Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences (WVE) Misses Revenue Estimates, Advances Clinical Trials | WVE Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 08, 2025

WAVE LIFE SCIENCES Earnings Results: $WVE Reports Quarterly Earnings - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 08, 2025
pulisher
May 08, 2025

Earnings Flash (WVE) Wave Life Sciences Reports Q1 Revenue $9.2M, vs. FactSet Est of $11.9M - marketscreener.com

May 08, 2025
pulisher
May 07, 2025

WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Kno - GuruFocus

May 07, 2025
pulisher
May 07, 2025

WAVE Life Sciences Earnings Preview - Nasdaq

May 07, 2025
pulisher
May 07, 2025

WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Closing Figures: Wave Life Sciences Ltd (WVE)’s Negative Finish at 6.41, Down -17.08 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Wave Life Sciences (WVE) Projected to Post Earnings on Thursday - Defense World

May 07, 2025

Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):